Skip to main content
HairCited

The Hormonal Background of Hair Loss in Non-Scarring Alopecias.

Barbara Owecka, Agata Tomaszewska, Krzysztof Dobrzeniecki, Maciej Owecki
Review Biomedicines 2024 17 citations
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D38540126'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
narrative review
Intervention
The Hormonal Background of Hair Loss in Non-Scarring Alopecias. None
Comparator
Placebo
Effect Direction
Mixed
Risk of Bias
Unclear

Abstract

Hair loss is a common clinical condition connected with serious psychological distress and reduced quality of life. Hormones play an essential role in the regulation of the hair growth cycle. This review focuses on the hormonal background of hair loss, including pathophysiology, underlying endocrine disorders, and possible treatment options for alopecia. In particular, the role of androgens, including dihydrotestosterone (DHT), testosterone (T), androstenedione (A4), dehydroepiandrosterone (DHEA), and its sulfate (DHEAS), has been studied in the context of androgenetic alopecia. Androgen excess may cause miniaturization of hair follicles (HFs) in the scalp. Moreover, hair loss may occur in the case of estrogen deficiency, appearing naturally during menopause. Also, thyroid hormones and thyroid dysfunctions are linked with the most common types of alopecia, including telogen effluvium (TE), alopecia areata (AA), and androgenetic alopecia. Particular emphasis is placed on the role of the hypothalamic-pituitary-adrenal axis hormones (corticotropin-releasing hormone, adrenocorticotropic hormone (ACTH), cortisol) in stress-induced alopecia. This article also briefly discusses hormonal therapies, including 5-alpha-reductase inhibitors (finasteride, dutasteride), spironolactone, bicalutamide, estrogens, and others.

Full Text

PDF
Loading PDF...

Tables

Table 2

MedicationMechanism of ActionRoute of AdministrationDoseIndication
Finasteride5α-reductase type II inhibitororal1 mg dailyAndrogenetic alopecia
topical0.25% solution (1 mL twice daily)
Dutasteride5α-reductase type I and II inhibitororal0.5 mg daily
SpironolactoneAR * antagonist,17α-hydroxylase inhibitororal25–200 mg daily
topical1% gel or 5% solution twice daily
BicalutamideAR antagonistoral10–50 mg daily
Cyproterone acetate5α-reductase inhibitor,AR antagonist, gonadotrophin secretion inhibitororal50 mg daily
ClascoteroneAR antagonisttopical1% cream
PyrilutamideAR antagonisttopical0.5% solution(1 mL once/twice daily)
Pumpkin seed oilHerbal 5α-reductase inhibitororal400 mg daily
EstradiolER agonist,elevation of sex hormone-binding globulin levelsoral1–2 mg dailymenopause,premature ovarian failure
LevothyroxineSynthetic version of human thyroxineoral25–200 µg dailyhypothyroidism

References

  1. Untitled
  2. Untitled
  3. Untitled
  4. Untitled
  5. Untitled
  6. Untitled
  7. Untitled
  8. Untitled
  9. Untitled
  10. Untitled
  11. Untitled
  12. Untitled
  13. Untitled
  14. Untitled
  15. Untitled
  16. Untitled
  17. Untitled
  18. Untitled
  19. Untitled
  20. Untitled
  21. Untitled
  22. Untitled
  23. Untitled
  24. Untitled
  25. Untitled
  26. Untitled
  27. Untitled
  28. Untitled
  29. Untitled
  30. Untitled
  31. Untitled
  32. Untitled
  33. Untitled
  34. Untitled
  35. Untitled
  36. Untitled
  37. Untitled
  38. Untitled
  39. Untitled
  40. Untitled
  41. Untitled
  42. Untitled
  43. Untitled
  44. Untitled
  45. Untitled
  46. Untitled
  47. Untitled
  48. Untitled
  49. Untitled
  50. Untitled
  51. Untitled
  52. Untitled
  53. Untitled
  54. Untitled
  55. Untitled
  56. Untitled
  57. Untitled
  58. Untitled
  59. Untitled
  60. Untitled
  61. Untitled
  62. Untitled
  63. Untitled
  64. Untitled
  65. Untitled
  66. Untitled
  67. Untitled
  68. Untitled
  69. Untitled
  70. Untitled
  71. Untitled
  72. Untitled
  73. Untitled
  74. Untitled
  75. Untitled
  76. Untitled
  77. Untitled
  78. Untitled
  79. Untitled
  80. Untitled
  81. Untitled
  82. Untitled
  83. Untitled
  84. Untitled
  85. Untitled
  86. Untitled
  87. Untitled
  88. Untitled
  89. Untitled
  90. Untitled
  91. Untitled
  92. Untitled
  93. Untitled
  94. Untitled
  95. Untitled
  96. Untitled
  97. Untitled
  98. Untitled
  99. Untitled
  100. Untitled
  101. Untitled
  102. Untitled
  103. Untitled
  104. Untitled
  105. Untitled
  106. Untitled
  107. Untitled
  108. Untitled
  109. Untitled
  110. Untitled
  111. Untitled
  112. Untitled
  113. Untitled

Used In Evidence Reviews

Similar Papers